Search Within

Isabelle C Riviere

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Meeting Abstract (121)
  2. Journal Article (75)
  3. Conference Paper (2)
  4. Review (2)
  5. Research Letter (1)
Groups
  1. Department of Medicine (201)
  2. GSK Faculty (201)
  3. Hematologic Malignancies, Division of (201)
  4. Molecular Pharmacology and Chemistry Program Faculty (201)
  5. Sloan Kettering Institute Faculty (201)
  6. Center for Hematologic Malignancies (200)

More Groups

People
  1. Michel Sadelain (200)
  2. Renier Brentjens (99)
  3. Xiuyan Wang (88)
  4. Jae Park (73)
  5. Kevin Curran (36)
  6. Brigitte Senechal (32)

More People

Years
  1. 2025 (1)
  2. 2023 (8)
  3. 2022 (10)
  4. 2021 (9)
  5. 2020 (6)
  6. 2019 (15)

More Years

Publications
  1. Blood (49)
  2. Molecular Therapy (31)
  3. Journal of Clinical Oncology (17)
  4. Cancer Research (8)
  5. Human Gene Therapy (8)
  6. Haematologica (6)

More Publications

Publishers
  1. Nature Publishing Group (53)
  2. American Society of Hematology (50)
  3. American Society of Clinical Oncology (18)
  4. American Association for Cancer Research (13)
  5. Elsevier Inc. (13)
  6. Mary Ann Liebert, Inc (8)

More Publishers

Results (201)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Promoting functional persistence in solid tumor CAR T-cell therapy: Mesothelin-targeted CAR (M28z1XXPD1DNR) with T-cell intrinsic PD1 dominant negative receptor
    Meeting Abstract

    Adusumilli, P. S.; Amador, A. M.; Chintala, N.; Hou, Z.; Offin, M.; Pineda, J.; Senechal, B.; Quach, H. T.; Bellis, R.; Banerjee, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; Rivière, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia
    Research Letter

    Perica, K.; Flynn, J.; Curran, K. J.; Rivere, I.; Wang, X.; Senechal, B.; Halton, E.; Diamonte, C.; Pineda, J.; Bernal, Y.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • CAR T cells: Building on the CD19 paradigm
    Review

    Globerson Levin, A.; Rivière, I.; Eshhar, Z.; Sadelain, M.
    European Journal of Immunology (2021)

    Fulltext@MSK | Save
  • Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy
    Journal Article

    Wudhikarn, K.; Flynn, J. R.; Rivière, I.; Gönen, M.; Wang, X.; Senechal, B.; Curran, K. J.; Roshal, M.; Maslak, P. G.; Geyer, M. B.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Decreased neuroprotective analytes on day of infusion of chimeric antigen receptor (CAR) T cells are associated with neurotoxicity
    Meeting Abstract

    Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Khakoo, Y.; Santomasso, B. D.; Riviere, I.; Sadelain, M.; Curran, K. J.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save
  • ADCLEC.syn1 is a novel combinatorial CAR platform for enhanced therapeutic index in AML
    Meeting Abstract

    Haubner, S.; Mansilla-Soto, J.; Nataraj, S.; Park, J.; Wang, X.; Rivière, I.; Sadelain, M.
    Molecular Therapy (2021)

    Fulltext@MSK | Save
  • Predictors for neurotoxicity on day of infusion of chimeric antigen receptor (CAR) T cells using discovery proteomics platform
    Meeting Abstract

    Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Auchincloss, T.; Klein, E.; Khakoo, Y.; Santomasso, B.; Senechal, B.; more...
    Cytotherapy (2021)

    Fulltext@MSK | Save
  • NOTCH and CAR signaling control T cell lineage commitment from pluripotent stem cells
    Meeting Abstract

    Van der Stegen, S.; Lindenbergh, P.; Petrovic, R.; Whitlock, B.; Clarke, R.; Valamehr, B.; Riviere, I.; Sadelain, M.
    Blood (2020)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory B-cell malignancies
    Meeting Abstract

    Park, J. H.; Riviere, I.; Sikder, D. S.; Bermudez, V. P.; Senechal, B.; Wang, X.; Auchincloss, T. H.; Diamonte, C.; Halton, E.; Palomba, M. L.; more...
    Blood (2020)

    Fulltext@MSK | Save